Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Pancreatic Juice and Secretion

Pancreatic Juice and Secretion

Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...

Gastritis-II: Pathophysiology

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for hereditary pancreatic diseases (EUROPAC-PLUS).

Neoplasia (New York, N.Y.)·2026

Same author

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

The Journal of antimicrobial chemotherapy·2026

Same author

Reporting of baseline characteristics in gastrointestinal cancer: A systematic review of surgical randomised controlled trials.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026

Same author

Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.

Lancet (London, England)·2026

Same author

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same author

A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026

Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026

Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026

Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026

Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026

Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026

See all related articles

Search research articles

Related Experiment Videos

Cationic trypsinogen mutations and pancreatitis.

Nathan Howes¹, William Greenhalf, Deborah D Stocken

¹Department of Surgery, Liverpool University, 5th Floor, University Clinical Department Building, Daulby Street, Liverpool, L69 3GA, United Kingdom.

Gastroenterology Clinics of North America

|November 6, 2004

Summary

This summary is machine-generated.

Hereditary pancreatitis, often caused by PRSS1 mutations, leads to early symptoms and later pancreatic insufficiency. Pancreatic cancer risk increases with age, independent of PRSS1 mutation type.

Related Experiment Videos

Area of Science:

Genetics
Gastroenterology
Pathophysiology

Background:

Hereditary pancreatitis is linked to PRSS1 mutations, impacting disease understanding.
Patients experience early symptoms and later endocrine/exocrine insufficiency.
Distinct phenotypes differentiate hereditary pancreatitis from other forms.

Purpose of the Study:

To elucidate the role of PRSS1 mutations in hereditary pancreatitis.
To analyze genotype-phenotype correlations in hereditary pancreatitis.
To assess pancreatic cancer risk in hereditary pancreatitis patients.

Main Methods:

Analysis of PRSS1 mutations in hereditary pancreatitis patients.
Correlation of genotype with disease presentation and progression.
Evaluation of pancreatic cancer risk factors.

Main Results:

80% of symptomatic patients have PRSS1 mutations, with minimal phenotypic differences among them.
R122H is the most common mutation, causing earlier presentation but not necessarily more aggressive disease.
Pancreatic cancer risk rises after age 40, irrespective of PRSS1 mutation type or inheritance pattern.

Conclusions:

PRSS1 mutations are key in hereditary pancreatitis, but age of symptom onset may not predict disease severity.
All hereditary pancreatitis patients face significant pancreatic cancer risk, increasing with age.
SPINK1 mutations' role in modifying PRSS1 effects requires further investigation.